Earnings Call: Verona Pharma Reports Q3 Results, Optimistic About Ohtuvaire
Daily NewsVerona Pharma PLC (VRNA) discussed its third-quarter financials and the commercial progress of its newly launched COPD treatment, Ohtuvayre, during its earnings c...
Read More